Nasdaq
$11.25▲ 0.18%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $451.5MShares out 40.1M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
9- 3d agoAfter-hours26.10.22 05:016-KKey event#●●●
Brainsway Ltd.
BrainsWay Ltd. will hold its Annual General Meeting of Shareholders on November 25, 2026, in Jerusalem, Israel. The agenda includes the re-appointment of independent auditors, the re-election of directors, and the approval of equity-based compensation for the CEO and directors. Shareholders and ADS holders of record as of October 26, 2026, are entitled to vote on these proposals.…more
$11.25+0.18%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 5d agoRegular26.10.20 01:006-KKey event
Brainsway Ltd.
BrainsWay has entered into a strategic collaboration with Inland Psychiatric Medical Group (IPMG), a behavioral health provider in Southern California. The partnership includes the installation of multiple Deep TMS systems at IPMG clinics and the joint exploration of clinical and research projects to advance interventional psychiatry.…more
$11.25+0.18%vs prev closeView filingShare - 10.13Pre-market26.10.13 20:306-KKey event
Brainsway Ltd.
BrainsWay announced that the U.S. insurance coverage for its SWIFT Accelerated Deep TMS protocol has expanded to over 70 million covered lives. This expansion marks a significant milestone in improving market access for the company's Deep TMS technology in treating major depressive disorder and obsessive-compulsive disorder.…more
$11.25+0.18%vs prev closeView filingShare
8 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 6d agoPre-market26.10.19 20:30#●●●#●●●
BrainsWay Announces Strategic Collaboration with Inland Psychiatry Medical Group…more
BrainsWay has entered a strategic partnership with Inland Psychiatry Medical Group to supply its Deep TMS systems and explore joint research projects. This collaboration aims to expand the application of interventional psychiatry treatments across Southern California.…more
$11.25+0.18%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.13Pre-market26.10.13 20:30
●●●●●●●● ●●●●● ●●●●●●
BrainsWay announced that its SWIFT Accelerated Deep TMS protocol is now covered by insurance for over 70 million lives in the U.S. This expansion in insurance coverage is expected to improve patient access and support broader adoption of the company's neurostimulation therapy.…more
$11.25+0.18%vs prev close - 9.8Pre-market26.09.08 20:30
●●●●●●●● ●●●●● ●●●●●●
BrainsWay announced positive pilot study results using its Deep TMS technology to treat depressive symptoms in patients with early-stage Alzheimer’s disease. The company noted that the technology is not yet FDA-cleared for this indication and requires further controlled clinical research.…more
$11.25+0.18%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report